について
Biomaterials is a multidisciplinary field that integrates biology, materials science, and engineering to design and develop substances that interact with biological systems. These materials, which can be natural or synthetic, are engineered to support, enhance, or replace biological functions, playing a pivotal role in medical and healthcare advancements. Researchers in biomaterials investigate their properties, biocompatibility, and applications in areas ranging from tissue engineering to drug delivery systems.
The scope of biomaterials encompasses cutting-edge technologies and innovative applications, including the development of smart and biodegradable materials, implants, and scaffolds for tissue regeneration. By enabling breakthroughs in regenerative medicine, prosthetics, and diagnostics, biomaterials contribute significantly to improving patient outcomes and addressing global health challenges. This field continues to evolve, driven by the pursuit of creating sustainable and functional solutions tailored to the complexities of human biology.

Why publish with us?
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
現在トレンドになっている記事はどれですか?
研究論文
- Designing a Compact High-precision Positioner with Large Stroke Capability for Nanoindentation Devices
- Maternal Knowledge and Practices in Caring for Children under Five with Pneumonia: A Cross-Sectional Study in Vietnam
- Properties of Indium Antimonide Nanocrystals as Nanoelectronic Elements
- Sorption-based Spectrophotometric Assay for Lead(II) with Immobilized Azo Ligand
- Evaluating Digital Imaging Technologies for Anogenital Injury Documentation in Sexual Assault Cases
- Study of the Histological Features of the Stroma of High-Grade Gliomas Depending on the Status of the Mutation in the IDH1 Gene
Advertisement